Foundation for Quality Assessment in Medical Laboratory Diagnostics

Publications

2024

RIVM-HBV-EQA-report

Vanhulle E, Simões M, ten Bruin H, Boland G, Brandenburg A, Benschop K. Diagnostic evaluation of the serological detection performance on HBV surface antigens in the Netherlands. RIVM report.

Evaluation of structural problems in the application of strict criteria for sperm morphology assessment

van den Hoven L, van Vrouwerff NJ, Dijkstra IM, Weeteling J, Brinkman JW, Eliveld J, Wetzels AMM. Evaluation of structural problems in the application of strict criteria for sperm morphology assessment. Andrology. 2025 Mar;13(3):512-518. doi: 10.1111/andr.13684. Epub 2024 Jun 24. PMID: 38924385; PMCID: PMC11867914.

Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations

Stemkens R, Mouhdad C, Franssen EJF, Touw D, Alffenaar JW, Te Brake LHM, Sturkenboom MGG, Aarnoutse RE. Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations. J Antimicrob Chemother. 2024 Jun 3;79(6):1346-1352. doi: 10.1093/jac/dkae105. PMID: 38581098; PMCID: PMC11144482.

Influence of ultrafiltration conditions on the measurement of unbound drug concentrations: flucloxacillin as an example.

Jager NGL, Van Ewijk-Beneken Kolmer E, Aarnoutse R, Te Brake LHM. Influence of ultrafiltration conditions on the measurement of unbound drug concentrations: flucloxacillin as an example. J Antimicrob Chemother. 2024 Apr 3:dkae092. doi: 10.1093/jac/dkae092. Epub ahead of print. PMID: 38569058.

Quality control in the Netherlands- todays practices and starting points for guidance and future research

van Rossum HH, van Schrojenstein Lantman M, Severens M, Vermeer HJ, Verboeket-van de Venne WPHG, Oosterhuis W, de Jonge N. Quality control in the Netherlands; todays practices and starting points for guidance and future research. Clin Chem Lab Med. 2024 Apr 26;62(11):2177-2184. doi: 10.1515/cclm-2024-0316. PMID: 38661089.

Investigating the Current Harmonization Status of Tumor Markers Using Global External Quality Assessment Programs: A Feasibility Study.

van Rossum HH, Holdenrieder S, Ballieux BEPB, Badrick TC, Yun YM, Zhang C, Patel D, Thelen M, Song J, Wojtalewicz N, Unsworth N, Vesper HW, Cui W, Ramanathan LV, Sturgeon C, Meng QH. Investigating the Current Harmonization Status of Tumor Markers Using Global External Quality Assessment Programs: A Feasibility Study. Clin Chem. 2024 Feb 22:hvae005. doi: 10.1093/clinchem/hvae005. Epub ahead of print. PMID: 38385453.

When bias becomes part of imprecision: how to use analytical performance specifications to determine acceptability of lot-lot variation and other sources of possibly unacceptable bias.

Thelen MHM, van Schrojenstein Lantman M. When bias becomes part of imprecision: how to use analytical performance specifications to determine acceptability of lot-lot variation and other sources of possibly unacceptable bias. Clin Chem Lab Med. 2024 Feb 8. doi: 10.1515/cclm-2023-1303. Epub ahead of print. PMID: 38353157.

Identification of gaps in the performance of routine microscopy for the diagnosis of parasitic infections revealed by the Dutch laboratory quality assessment scheme

Boonstra MB, Koelewijn R, Brienen EAT, Tassche-Borggreve K, Kortbeek LM, Mank TG, Mulder B, Stelma F, van Lieshout L, van Hellemond JJ. Identification of gaps in the performance of routine microscopy for the diagnosis of parasitic infections revealed by the Dutch laboratory quality assessment scheme. Clin Microbiol Infect. 2024 Jun;30(6):833-835. doi: 10.1016/j.cmi.2024.02.018. Epub 2024 Feb 23. PMID: 38402953.

To rule-in, or not to falsely rule-out, that is the question: evaluation of hs-cTnT EQA performance in light of the ESC-2020 guideline.

van Schrojenstein Lantman M, Grobben R, van Herwaarden AE, van Berkel M, Schaap J, Thelen M. To rule-in, or not to falsely rule-out, that is the question: evaluation of hs-cTnT EQA performance in light of the ESC-2020 guideline. Clin Chem Lab Med. 2024 Feb 7. doi: 10.1515/cclm-2023-1226. Epub ahead of print. PMID: 38353154.

2023

APS calculator- a data-driven tool for setting outcome-based analytical performance specifications for measurement uncertainty using specific clinical requirements and population data

Çubukçu HC, Vanstapel F, Thelen M, van Schrojenstein Lantman M, Bernabeu-Andreu FA, Meško Brguljan P, Milinkovic N, Linko S, Panteghini M, Boursier G. APS calculator: a data-driven tool for setting outcome-based analytical performance specifications for measurement uncertainty using specific clinical requirements and population data. Clin Chem Lab Med. 2023 Nov 17;62(4):597-607. doi: 10.1515/cclm-2023-0740. PMID: 37978287.